| http://www.w3.org/ns/prov#value | - In addition to identifying medicines in development for conditions and diseases such as septic shock, ovarian cancer, sickle cell disease, and Lou Gehrig???s disease (amyotrophic lateral sclerosis), which haven???t had any new product approvals in the last ten years, the report offers positive news for the rare disease community: one third of the products currently in clinical development have a r
|
